Company DrazCanna, Inc.

Equities

DZCA

US8257842000

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 12:22:07 2024-05-15 EDT			5-day change	1st Jan Change
0.043 ^USD	-71.12%		0.00%	-88.53%

2023	EV Electra LTD entered into a letter of intent to acquire DrazCanna, Inc. in a reverse merger transaction for $980 million.	CI
2023	Drazcanna, Inc. Announces CEO Changes	CI

DrazCanna, Inc. is engaged in providing cannabis products. The Company's products include flowers, edibles, extracts, topicals, and cannabidiol (CBD) products. The Company's extraction processes include CBD distillation for use in a line of topicals, edibles, oils and concentrates for consumer use. Its topical products provide opportunities for skin health and pain relief, such as anti-aging, skin disorder, pain relief and wound healing.

Number of employees: 49

USD in Million	2014	Weight	2015	Weight	Delta
Virtual and Classroom Learning Solutions 100.0 %	0	100.0 %	2	100.0 %	+635.10%

USD in Million	2014	Weight	2015	Weight	Delta
United States 100.0 %	0	100.0 %	2	100.0 %	+635.10%

Managers	Title	Age	Since
Jihad Mohammad CEO	Chief Executive Officer	-	23-09-19
Hussein A. Anani CEO	Chief Executive Officer	-	20-12-31
Mouktar Makkouk DFI	Director of Finance/CFO	-	23-09-19

Members of the board	Title	Age	Since
Jihad Mohammad CEO	Chief Executive Officer	-	23-09-19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	9,949,644	9,378,304 ( 94.26 %)	0	94.26 %
Stock B	0	30	0	0

DrazCanna, Inc.

835 Mason Street Suite C-116

48124, Dearborn Heights

http://www.drazcanna.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
DRAZCANNA, INC.	-88.53%	1.43M
MODERNA, INC.	+29.77%	49.18B
IQVIA HOLDINGS INC.	+1.00%	42.11B
LONZA GROUP AG	+50.47%	40.37B
CELLTRION, INC.	-5.26%	28.85B
ICON PUBLIC LIMITED COMPANY	+13.68%	26.09B
ALNYLAM PHARMACEUTICALS, INC.	-22.99%	18.71B
BIO-TECHNE CORPORATION	+8.22%	13.26B
MEDPACE HOLDINGS, INC.	+32.41%	12.32B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.62%	11.99B

Other Biotechnology & Medical Research